Table 3 The independent predictors of unknown and unfavorable intensive phase treatment outcome among patients treated for MDR-TB in Ethiopia, 2009–2014
Variables | Unknown outcome | |
|---|---|---|
CRRR 95% CI | ARRR 95% CI | |
Model of care | ||
Ambulatory | 2.107 (1.386, 3.203) ** | 3.158 (1.612, 6.185) ** |
Hospitalized | 1 | 1 |
Residence | ||
Urban | 0.538 (0.361,0.803) ** | 0.370 (0.199, 0.66) ** |
Rural | 1 | 1 |
TB Treatment supporter | ||
Yes | 0.964 (0.634, 1.465) | 0.022 (0.002, 0.231) ** |
Unknown | 3.383 (1.632, 7.012) ** | 0.332 (0.083, 1.319) |
No | 1 | 1 |
Resistances to: | ||
Four drugs (RHES) | 0.293 (0.165,0.523) ** | 0.741 (0.267, 2.059) |
Three drugs (RHE) | 0.254 (0.106,0.609) ** | 0.185 (0.03, 0.9426) * |
Two drugs (RH) | 0.285 (0.178,0.457) ** | 0.350 (0.177, 0.693) ** |
One drug(R) | 1 | 1 |
unfavorable outcome | ||
CRRR 95% CI | ARRR 95%CI | |
Age | 1.039 (1.022, 1.056) ** | 1.047 (1.024, 1.072) ** |
History of hypokalemia | ||
Yes | 0.567 (0.371, 0.867)** | 0.512 (0.280, 0.939) * |
Unknown | 1.548 (0.857, 2.797) | 1.454 (0.499, 4.242) |
No | 1 | 1 |